Improving screening for major depressive disorder

被引:3
|
作者
Sharp, Lauren K. [1 ,4 ]
Montgomery, Susan L. [2 ]
Williams, Russell W. [3 ]
机构
[1] NextCare Urgent Care, Dumfries, VA USA
[2] Univ S Alabama, Coll Nursing, Community Mental Hlth Nursing, Mobile, AL USA
[3] Stafford Primary Care Associates, Stafford, VA USA
[4] 3990 Fettler Pk Dr, Dumfries, VA 22025 USA
关键词
Depression management; depression screening; primary care; quality improvement; PRIMARY-CARE; VALIDITY; ADULTS;
D O I
10.1097/JXX.0000000000000817
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background:Depression affects up to 20% of primary care patients and negatively affects patients' mental and physical health.Local Problem:At a primary care clinic, a review of 291 patient records revealed that no patients were being screened for depression using a validated and reliable tool.Methods:The problem was addressed through the implementation of a depression screening and management protocol based on the U.S. Preventive Services Task Force guidelines. Processes used were recommended by the American College of Preventive Medicine and Institute for Clinical Systems Improvement.Interventions:This project implemented a protocol to screen, treat, and manage patients with depression at this primary care clinic. Analysis compared preimplementation and postimplementation metrics, including the number of patients screened for depression, newly diagnosed with depression, offered antidepressants, offered referral, and managed with follow-up.Results:Implementing a depression screening and management protocol in this clinic significantly increased depression screenings, the percent of patients newly diagnosed with depression, and the number of patients offered treatment.Conclusion:This quality improvement (QI) project improved screening, diagnosis, and management of patients with depression in this primary care clinic. A future QI project for this clinic should focus on measures to track improvements in patients with depression at this primary care clinic.
引用
收藏
页码:71 / 78
页数:8
相关论文
共 50 条
  • [31] SUMOylation and Major Depressive Disorder
    Jeoung, Seok-Won
    Park, Hyun-Sun
    Ryoo, Zae Young
    Cho, Dong-Hyung
    Lee, Hyun-Shik
    Ryu, Hong-Yeoul
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [32] Vilazodone In Major Depressive Disorder
    Frampton, James E.
    CNS DRUGS, 2011, 25 (07) : 615 - 627
  • [33] MAJOR DEPRESSIVE DISORDER IN A PRESCHOOLER
    KASHANI, JH
    CARLSON, GA
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1985, 24 (04): : 490 - 494
  • [34] MAJOR DEPRESSIVE DISORDER AND IMMUNITY
    STEIN, M
    SCHLEIFER, SJ
    KELLER, SE
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 905 - 905
  • [35] Teleconsultation in major depressive disorder
    Mota-Pereira, J.
    Fonte, D.
    Teixeira, R. J.
    Carvalho, S.
    EUROPEAN PSYCHIATRY, 2019, 56 : S384 - S384
  • [36] Subtyping Major Depressive Disorder
    Lichtenberg, Pesach
    Belmaker, R. H.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2010, 79 (03) : 131 - 135
  • [37] Treatment for major depressive disorder
    Zhang, X.
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2015, 84 : 81 - 81
  • [38] Neurobiology of Major Depressive Disorder
    Villanueva, Rosa
    NEURAL PLASTICITY, 2013, 2013
  • [39] Aripiprazole - In major depressive disorder
    Weber, Juliane
    Lyseng-Williamson, Katherine A.
    Scott, Lesley J.
    CNS DRUGS, 2008, 22 (10) : 807 - 813
  • [40] Seltorexant for major depressive disorder
    Valentino, Kyle
    Teopiz, Kayla M.
    Wong, Sabrina
    Zhang, Melanie C.
    Le, Gia Han
    Choi, Hayun
    Ballum, Hana
    Dri, Christine
    Cheung, William
    Mcintyre, Roger S.
    EXPERT OPINION ON EMERGING DRUGS, 2025, 30 (01) : 41 - 51